Page 103 - Программа - Всероссийский конгресс с международным участием «Нейронауки: интеграция теории и практики», 18-19 ноября 2022 года, Онлайн

Russian Military Medical
SCIENTIFIC REVIEWS Vol. 41 (4) 2022 Academy Reports
452

associated demyelination // J. Neurol. Neurosurg. Psychiatry. 2018. 2021. Vol. 20, No. 9. P. 762–772. Erratum in: Lancet Neurol. 2021.
Vol. 89, No. 2. P. 127–137. DOI: 10.1136/jnnp-2017-316880 Vol. 20, No. 10. P. e6. Erratum in: Lancet Neurol. 2022. Vol. 21, No. 1.
34. Mehta P., McAuley D.F., Brown M., et al. COVID-19: consider cytokine P. e1. PMID: 34418402. DOI: 10.1016/s1474-4422(21)00218-0
storm syndromes and immunosuppression // Lancet. 2020. Vol. 395, 39. Yi M.H., Lee Y.S., Kang J.W., et al. NFAT5-dependent expression
No. 10229. P. 1033–1034. DOI: 10.1016/s0140–6736(20)30628-0 of AQP4 in astrocytes // Cell. Mol. Neurobiol. 2013. Vol. 33, No. 2.
35. Lambe J., McGinley M.P., Moss B.P., et al. Myelin oligodendro- P. 223–232. DOI: 10.1007/s10571-012-9889-0
cyte glycoprotein-IgG associated disorders (MOGAD) following SARS- 40. Carnero Contentti E., Correale J. Neuromyelitis optica spectrum dis-
CoV-2 infection: A case series // J. Neuroimmunol. 2022. Vol. 370. orders: from pathophysiology to therapeutic strategies // J. Neuroinflam-
P. 577933. DOI: 10.1016/j.jneuroim.2022.577933 mation. 2021. Vol. 18, No. 1. P. 208. DOI: 10.1186/s12974-021-02249-1
36. Colantonio M.A., Nwafor D.C., Jaiswal S., et al. Myelin oligo- 41. Machado C., Amorim J., Rocha J., et al. Neuromyelitis optica
dendrocyte glycoprotein antibody-associated optic neuritis and my- spectrum disorder and varicella-zoster infection // J. Neurol. Sci.
elitis in COVID-19: a case report and a review of the literature // 2015. Vol. 358, No. 1–2. P. 520–521. DOI: 10.1016/j.jns.2015.09.374
Egypt. J. Neurol. Psychiatr. Neurosurg. 2022. Vol. 58, No. 1. P. 62. 42. Harris M.K., Maghzi A.H., Etemadifar M., et al. Acute demyelinating
DOI: 10.1186/s41983-022-00496-4 disorders of the central nervous system // Curr. Treat. Options Neurol.
37. Mariotto S., Carta S., Dinoto A., et al. Is there a correlation be- 2009. Vol. 11, No. 1. P. 55–63. DOI: 10.1007/s11940-009-0008-6
tween MOG-associated disorder and SARS-CoV-2 infection? // Eur. 43. Mirmosayyeb O., Ghaffary E.M., Bagherieh S., et al. Post
J. Neurol. 2022. Vol. 29, No. 6. P. 1855–1858. DOI: 10.1111/ene.15304 COVID-19 infection neuromyelitis optica spectrum disorder (NMOSD):
38. Marignier R., Hacohen Y., Cobo-Calvo A., et al. Myelin-oligoden- A case report-based systematic review // Mult. Scler. Relat. Disord.
drocyte glycoprotein antibody-associated disease // Lancet Neurol. 2022. Vol. 60. P. 103697. DOI: 10.1016/j.msard.2022.103697

REFERENCES

1. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in 11. Ariño H, Heartshorne R, Michael BD, et al. Neuroim-
a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. mune disorders in COVID-19. J Neurol. 2022;269(6):2827–2839.
2020;5(7):819–824. DOI: 10.1001/jamacardio.2020.1096 DOI: 10.1007/s00415–022–11050-w
2. Zoghi G, Moosavy SH, Yavarian S, et al. Gastrointesti- 12. Liu JM, Tan BH, Wu S, et al. Evidence of central nervous sys-
nal implications in COVID-19. BMC Infect Dis. 2021;21(1):1135. tem infection and neuroinvasive routes, as well as neurological
DOI: 10.1186/s12879-021-06824-y involvement, in the lethality of SARS-CoV-2 infection. J Med Virol.
3. Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz Martin 2021;93(3):1304–1313. DOI: 10.1002/jmv.26570
AJ. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 13. Arbour N, Ekandé S, Côté G, et al. Persistent infection of human
2021;46(3):100742. DOI: 10.1016/j.cpcardiol.2020.100742 oligodendrocytic and neuroglial cell lines by human coronavirus 229E.
4. Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations J Virol. 1999;73(4):3326–3337. DOI: 10.1128/jvi.73.4.3326–3337.1999
of COVID-19: Report of three cases and a review of literature. J Der- 14. Sarwar S, Rogers S, Mohamed AS, et al. Multiple Sclerosis Fol-
matol Sci. 2020;98(2):75–81. DOI: 10.1016/j.jdermsci.2020.04.011 lowing SARS-CoV-2 Infection: A Case Report and Literature Review.
5. Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Cureus. 2021;13(10): e19036. DOI: 10.7759/cureus.19036
Affect the Eyes? A Review of Coronaviruses and Ocular Implica- 15. Fleischer M, Köhrmann M, Dolff S, et al. Observational cohort
tions in Humans and Animals. Ocul Immunol Inflamm. 2020;28(3): study of neurological involvement among patients with SARS-CoV-2
391–395. DOI: 10.1080/09273948.2020.1738501 infection. Ther Adv Neurol Disord. 2021;14:1756286421993701.
6. Espíndola OM, Gomes YCP, Brandão CO, et al. Inflamma- DOI: 10.1177/175628642199370
tory Cytokine Patterns Associated with Neurological Diseases in 16. Jarius S, Pache F, Körtvelyessy P, et al. Cerebrospinal fluid findings
Coronavirus Disease 2019. Ann Neurol. 2021;89(5):1041–1045. in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
DOI: 10.1002/ana.26041 J Neuroinflammation. 2022;19(1):19. DOI: 10.1186/s12974-021-02339-0
7. Bernard-Valnet R, Perriot S, Canales M, et al. Encephalopa- 17. Remsik J, Wilcox JA, Babady NE, et al. Inflammatory Leptomeninge-
thies Associated With Severe COVID-19 Present Neurovascular al Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
Unit Alterations Without Evidence for Strong Neuroinflamma- Cancer Cell. 2021;39(2):276–283.e3. DOI: 10.1016/j.ccell.2021.01.007
tion. Neurol Neuroimmunol Neuroinflamm. 2021;8(5): e1029. 18. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of
DOI: 10.1212/nxi.0000000000001029 post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264.
8. Moody R, Wilson K, Flanagan KL, et al. Adaptive Immunity and DOI: 10.1038/s41586-021-03553-9
the Risk of Autoreactivity in COVID-19. Int J Mol Sci. 2021;22(16):8965. 19. Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instru-
DOI: 10.3390/ijms22168965 mental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792.
9. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavi- DOI: 10.1016/j.autrev.2021.102792
rus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. 20. Baranzini SE, Wang J, Gibson RA, et al. Genome-wide association
DOI: 10.1056/nejmoa2002032 analysis of susceptibility and clinical phenotype in multiple sclerosis.
10. Chou SH, Beghi E, Helbok R, et al. Global Incidence of Neu- Hum Mol Genet. 2009;18(4):767–778. DOI: 10.1093/hmg/ddn388
rological Manifestations Among Patients Hospitalized With 21. Lourenço CM, Dupré N, Rivière JB, et al. Expanding the differen-
COVID-19-A Report for the GCS-NeuroCOVID Consortium and tial diagnosis of inherited neuropathies with non-uniform conduction:
the ENERGY Consortium. JAMA Netw Open. 2021;4(5):e2112131. Andermann syndrome. J Peripher Nerv Syst. 2012;17(1):123–127.
DOI: 10.1001/jamanetworkopen.2021.12131 DOI: 10.1111/j.1529-8027.2012.00374.x
DOI: https://doi.org/10.17816/rmmar111889